Homeopathy: From Origins to Modern Practice

By Maq Masi · 8 Nov 2026

Important: This article is for general information and education only. It is not medical advice and is not intended to diagnose, treat, cure or prevent any disease. Always consult a qualified healthcare professional about any health concern. Please read the full Disclaimer at the end of the article.

At a glance

• What it is: a system of medicine founded by Samuel Hahnemann in Germany in 1796, based on the principle “let like be treated by like” and on highly diluted, shaken preparations.
• Where it stands today: taught and regulated as a medical system in some countries, notably India; manufactured to recognised pharmacopoeial and GMP standards in Europe, the UK, the US and elsewhere.
• Patient experience and research: many patients and practitioners report real benefit, and supportive studies have been published in mainstream medical journals. Scientific opinion on how remedies act remains divided; Part IV summarises the research so readers can decide for themselves.
• Safety: homeopathic medicines are generally regarded as low in direct risk, and health authorities and homeopathic bodies agree they should be used alongside, not instead of, medical care for serious illness.

How to use this article

The article is arranged in five parts, followed by a disclaimer and appendices.

Part	What it covers
I. History and philosophy	Hahnemann, the Organon, the great homeopaths, worldwide spread
II. Homeopathic practice	Philosophy and the Organon, materia medica, repertory and pharmacy, provings, polychrests and trios, miasms, schools, Bach remedies, case-taking and remedy matching, potency selection, Hering’s law
III. Medicines and manufacture	Preparation and potency notation, forms of medicines, pharmacopoeias, GMP facilities and cleanroom grades
IV. Patient experience, research and safety	What patients value, the research, and safety considerations
V. Professional practice and regulation	Professional standards, advertising rules, UK regulation and product labels, and regulation in other countries

A timeline, glossary and references appear in the Appendices.

Part I: History and philosophy

How homeopathy began, the ideas it was built on, the people who developed it, and how it spread around the world.

Introduction

How does a system of medicine survive for more than two centuries, cross national boundaries, establish medical colleges and hospitals, develop its own pharmaceutical standards, and continue attracting practitioners and patients in every generation?

Homeopathy presents precisely this question. It originated in Germany towards the end of the eighteenth century, spread throughout Europe and America, developed a substantial body of medical literature, and eventually became part of formal medical education and regulation in several countries, particularly India. Its preparations are manufactured under recognised pharmaceutical procedures, and its theories of therapeutic action continue to be debated and researched.

What makes homeopathy distinctive is its completeness. It is not merely a collection of herbal remedies or a method of preparing highly diluted substances. It is an attempt to construct a complete medical system: a philosophy of disease, a method of observing patients, a way of investigating medicinal substances, rules for selecting treatment, pharmaceutical preparation, and a framework for interpreting recovery.

To understand homeopathy properly, we must examine not only its founder but also the physicians, pharmacists and scholars who expanded, questioned and sometimes departed from his original ideas. We must also look at how its medicines are made, how it is practised today, and how its research continues to develop.

This article aims to give practitioners, students and the wider public an accurate, balanced account of homeopathy: its history, practice, medicines, research and regulation, so that readers can form their own view. Respect for the tradition and honesty about the evidence are not in conflict. Both are needed if people are to make informed choices.

Perhaps the most useful starting point is to ask why homeopathy was invented at all.

The physician who questioned conventional medicine

Christian Friedrich Samuel Hahnemann was born in Meissen, Saxony, in 1755. He studied medicine at Leipzig, Vienna and Erlangen, obtaining his medical degree from Erlangen in 1779. His early professional life coincided with a period when European medicine routinely used bloodletting, purging, emetics, mercury and other aggressive interventions.

Many of these treatments rested on prevailing theories of disease rather than reliable clinical evidence, and their harmful effects were often considerable. Hahnemann became increasingly dissatisfied with the medicine of his time. For a period he largely withdrew from practice and supported himself through chemistry, pharmacy and the translation of scientific works.

In 1790, while translating William Cullen’s A Treatise of the Materia Medica, he questioned Cullen’s explanation of how cinchona bark (the source of quinine) worked against intermittent fevers. Hahnemann reportedly took cinchona himself and experienced symptoms he interpreted as resembling those of malaria.

From this experience he developed the proposition that a substance capable of producing certain symptoms in a healthy person might relieve similar symptoms in a sick person. He expressed this as similia similibus curentur, “let like be treated by like”.

The experiment became one of the most influential in the history of medicine, and its interpretation has been discussed ever since.

The observation became the foundation of a new system. In 1796 he published an essay on a new principle for finding the curative powers of drugs, a date commonly recognised as the formal beginning of homeopathy.

Hahnemann then introduced the systematic testing of medicinal substances on healthy volunteers, known as provings. Rather than relying on inherited claims, he recorded the symptoms that followed administration, so they could be compared with the symptoms of sick patients.

This was an important step: it made the observation of medicinal effects central to prescribing, at a time when much therapy was purely theoretical. Proving methods have since been refined, and modern provings commonly use standardised protocols, blinding and placebo comparison.

It is also fair to note what Hahnemann got right for his era. He argued against bloodletting and polypharmacy, urged single medicines in small doses, and stressed diet, hygiene, fresh air and humane treatment of the mentally ill.

The Organon and the philosophy of homeopathy

In 1810 Hahnemann published the first edition of the Organon of Rational Medicine, later retitled the Organon of the Healing Art and widely known in English as the Organon of Medicine.

The work sets out the physician’s responsibility, the nature of disease, the investigation of medicines, the selection of remedies, the administration of doses and the observation of recovery. Its numbered paragraphs, called aphorisms, are still cited by homeopaths today.

Hahnemann revised the Organon repeatedly. Five editions appeared during his lifetime. The sixth, completed in manuscript in 1842, was published posthumously in 1921. These revisions matter: his views on dose, repetition and potentisation changed considerably over time, and practitioners who follow different editions may practise quite differently.

In the Organon he described health and disease through the concept of a vital force, a dynamic principle believed to regulate the living organism. Disease was a disturbance of this principle, expressed through observable symptoms. The concept of the vital force remains central to classical homeopathic thinking.

Hahnemann argued that the totality of symptoms should guide remedy selection, giving particular weight to unusual, characteristic and individualising symptoms rather than the name of the disease alone.

His other major works include Materia Medica Pura, issued in volumes from 1811, and The Chronic Diseases, from 1828. The latter introduced his theory of chronic miasms, chiefly psora, sycosis and syphilis, which he regarded as underlying causes of persistent illness. The theory of miasms remains influential in classical practice and is interpreted in different ways by modern homeopaths.

These writings provided the philosophical foundation on which later schools of homeopathic practice were built.

The physicians who developed homeopathy

Homeopathy might have remained a small German movement without the physicians, pharmacists and scholars who carried it into other countries. Their approaches were not identical, and the history of homeopathy is as much a history of disagreement about how to interpret Hahnemann as of repeating him.

Figure	Dates	Main contribution	Distinctive emphasis
Constantine Hering	1800–1880	Founder of American homeopathy; The Guiding Symptoms of Our Materia Medica	Provings, institutions; name later attached to the “law of cure”
Clemens von Bönninghausen	1785–1864	Therapeutic Pocket Book (1846)	Location, sensation, modalities and concomitant symptoms
James Tyler Kent	1849–1916	Lectures on Homoeopathic Philosophy; Repertory of the Homoeopathic Materia Medica	Mental and emotional symptoms, constitution, single remedy, high potencies
William Boericke	1849–1929	Pocket Manual of Homoeopathic Materia Medica	A concise, widely used reference for everyday prescribing
John Henry Clarke	1853–1931	A Dictionary of Practical Materia Medica	Synthesis of provings, toxicology and clinical observation
Richard Hughes	1836–1902	Writing and teaching in Britain	A more pathological, clinically oriented homeopathy
Margaret Lucy Tyler	1857–1943	Homoeopathic Drug Pictures	Accessible remedy portraits; teaching in Britain
Cyrus Maxwell Boger	1861–1935	Repertory work building on Bönninghausen	Causation, timing, modalities and pathology combined

Clemens von Bönninghausen, born in the Netherlands and active in Germany, trained in law and worked as an agricultural administrator and botanist. Although not a conventionally trained physician, he became a close collaborator of Hahnemann and a pioneer of the repertory.

Other influential contributors included Timothy Field Allen, Adolph Lippe, Henry C. Allen, E. B. Nash and Herbert A. Roberts. Some emphasised the totality of symptoms, others the most characteristic features, constitutional interpretation, clinical pathology, or the circumstances that make symptoms better or worse.

Why physicians turned to homeopathy

Many of homeopathy’s leading figures were conventionally qualified doctors. Their reasons for converting changed as medicine itself changed, from an era of harmful “heroic” treatments to the eve of the antibiotic age.

Three eras of medicine

Period	State of conventional medicine	Why homeopathy appealed
c. 1780–1850: “heroic” medicine	Routine bloodletting, leeches, mercury (calomel), purging, vomiting and blistering, often in large doses	Gentle, small doses and careful observation offered an alternative to treatments that frequently harmed patients
c. 1850–1900: decline of heroic medicine	Bloodletting fell from favour after studies such as Pierre Louis’s in the 1830s showed it did not help pneumonia; germ theory was emerging, but effective drugs remained few, and some doctors turned to “therapeutic nihilism”	Homeopathy offered an active, individualised treatment when conventional medicine had little to give
c. 1900–1940s: scientific medicine before antibiotics	Laboratory medicine, surgery and vaccines advanced rapidly, but chronic illness and many infections had no effective treatment until penicillin in the 1940s	Physicians sought ways to support the body’s own responses and to bridge homeopathy and science

Physicians who adopted homeopathy

Physician	Dates and country	How they came to homeopathy	Their view and contribution
Constantine Hering	1800–1880, Germany and USA	As a Leipzig student in the early 1820s he was reportedly asked to write a book refuting homeopathy. While studying it, he developed a seriously infected dissection wound, recovered under homeopathic treatment, and converted	Regarded homeopathy as a science of observation; carried out extensive provings; founded homeopathic schools in Pennsylvania
Hans Burch Gram	1786–1840, Denmark and USA	Boston-born, trained in medicine in Copenhagen, where he learned homeopathy	Introduced homeopathy to the United States in 1825
Frederic Quin	1799–1878, Britain	An Edinburgh-trained physician who met Hahnemann in the 1820s	Brought homeopathy to Britain in 1827; founded the British Homoeopathic Society (1844) and the London Homoeopathic Hospital (1849)
Mahendralal Sircar	1833–1904, India	Among the first Calcutta University medical graduates; asked to review a homeopathic book in order to criticise it, he was instead persuaded, and declared his support publicly in 1867 at a medical association meeting, at the cost of his standing with colleagues	Founded the Calcutta Journal of Medicine and helped establish homeopathy in India; also founded the Indian Association for the Cultivation of Science (1876)
James Tyler Kent	1849–1916, USA	Trained as an “eclectic” physician; according to the usual account, his wife’s serious illness did not respond to his treatment but improved under a homeopath, after which he studied homeopathy (c. 1879)	Developed classical, constitutional prescribing and the repertory that bears his name
Edward Bach	1886–1936, Britain	A bacteriologist who joined the London Homoeopathic Hospital in 1919, read the Organon, and saw parallels between Hahnemann’s ideas and his own bacterial vaccine work	Developed the bowel nosodes, then his flower remedy system
August Bier	1861–1949, Germany	One of Germany’s most eminent surgeons, a pioneer of spinal anaesthesia, who became interested in homeopathy later in his career	His public support in 1925, asking how medicine should regard homeopathy, gave it unusual respectability among German doctors
Hans-Heinrich Reckeweg	1905–1985, Germany	Studied medicine in the 1920s; his father had used homeopathy for his own illnesses, and in Berlin he encountered it through August Bier	Sought to “build a bridge” between homeopathy and conventional medicine; founded Heel (1936) and developed homotoxicology (1948–49)

Physicians who opposed it

Homeopathy also had prominent medical critics from the start. In 1842 the American physician Oliver Wendell Holmes attacked it in Homoeopathy and its Kindred Delusions, arguing that its doses could have no effect. In 1846 the British physician John Forbes reviewed it more sympathetically: he concluded that homeopathic patients often recovered because illness tends to resolve on its own, and argued that conventional doctors should learn from this to abandon harmful treatments. Medical societies in Britain and America at times barred members from consulting with homeopaths.

Two interpretations

The historians’ view. Many historians of medicine argue that nineteenth-century homeopathy succeeded partly because it avoided the harm of heroic treatments, allowed natural recovery, and gave patients careful attention. On this view, homeopathy helped push conventional medicine towards gentler, more evidence-based practice.

The homeopaths’ view. Homeopaths argue that these physicians were trained observers who converted because of results they saw, often in serious cases, and not merely because homeopathy did less harm. They point to records such as the London Homoeopathic Hospital’s reported cholera mortality in 1854, which was substantially lower than that of other London hospitals; critics note that such figures may reflect differences in patients and in how cases were counted.

Readers can weigh these interpretations alongside the research discussed in Part IV.

How homeopathy spread across the world

Germany remained the birthplace of homeopathy and an important centre of pharmaceutical development. German physicians, pharmacists and manufacturers helped standardise tinctures, triturations, dilutions and potentisation methods.

France became an influential centre of practice and industrial manufacture, developing both single remedies and combination products.

Britain developed homeopathic hospitals, dispensaries, professional bodies and a substantial literature. The London Homoeopathic Hospital, founded in 1849, later became the Royal London Hospital for Integrated Medicine.

The United States saw particularly extensive growth in the nineteenth century. The American Institute of Homeopathy was founded in 1844, and homeopathic colleges and hospitals operated in many states, including Hahnemann Medical College in Philadelphia and a homeopathic department at the University of Michigan. Most later merged, changed their curricula or closed as medical education was reformed around laboratory science in the early twentieth century.

India became one of the world’s largest centres of organised homeopathic education and practice. The Bachelor of Homoeopathic Medicine and Surgery (BHMS) is taught in colleges affiliated with universities, alongside postgraduate courses, teaching hospitals and research institutes. The National Commission for Homoeopathy regulates education and professional standards, and the Central Council for Research in Homoeopathy conducts research, both under the Ministry of Ayush.

Brazil also recognises homeopathy as a medical specialty, with its own education and pharmacopoeia. Switzerland, Italy, Belgium, Spain and other countries contributed through medical societies, training and manufacturing.

The official position of homeopathy has changed considerably in recent decades and continues to differ widely between countries. For example, NHS England advised in 2017 that homeopathy should no longer be prescribed on the NHS, and France ended state reimbursement of homeopathic medicines in 2021, while Switzerland and India continue to give it formal recognition. Readers should check the current position in their own country.

These institutions demonstrate the historical and cultural influence of homeopathy. Questions of effectiveness are discussed separately in Part IV.

Homeopathy around the world today

Homeopathy is now one of the most widely used forms of traditional and complementary medicine in the world. In its 2019 global report, the World Health Organization listed homeopathy among the most common such practices across its member states, 170 of which reported use of traditional and complementary medicine.

Country	Status of homeopathy
India	A recognised national system of medicine under the Ministry of Ayush, with about 345,000 registered homoeopathic doctors, more than 8,500 government homoeopathy dispensaries, nearly 300 teaching institutions, and its own research council and pharmacopoeia
United States	The source of much of homeopathy’s classical literature, including the works of Hering, Kent, Boericke, T. F. Allen, H. C. Allen, Nash, Boger and Roberts. The American Institute of Homeopathy (1844) is the oldest national medical association in the country, and in the late nineteenth century homeopathic colleges and hospitals operated in many states. The Homoeopathic Pharmacopoeia of the United States has been recognised as an official compendium under the Federal Food, Drug, and Cosmetic Act since 1938, a provision introduced by its sponsor, Senator Royal Copeland, himself a homeopathic physician. Arizona, Connecticut and Nevada offer licensure as a homeopathic physician to medical and osteopathic doctors
Switzerland	Following a 2009 national vote in which two-thirds of voters supported complementary medicine, physician-delivered classical homeopathy has been covered by compulsory basic health insurance since 2017
Brazil	Recognised as a medical specialty by the Federal Council of Medicine since 1980, and offered within the public health system (SUS) under the National Policy on Integrative and Complementary Practices since 2006
Germany	Homeopathy’s birthplace, with a long tradition of medically qualified homeopaths, a national homeopathic pharmacopoeia and major manufacturers
United Kingdom	A history of homeopathic hospitals and royal patronage dating back to the nineteenth century; products are regulated by the MHRA, and practitioners include both medically qualified and professional homeopaths

Homeopathy is also widely practised across continental Europe, Latin America and South Asia, and homeopathic medicines are manufactured in many countries to recognised pharmacopoeial and GMP standards.

Part II: Homeopathic practice

The literature practitioners use, the main schools and related traditions, and how a case is taken, a potency chosen and progress judged.

The literature of homeopathy: philosophy, materia medica, repertory and pharmacy

Homeopathy developed four main kinds of literature, which work together.

• The Organon and the wider body of homeopathic philosophy supply the theoretical framework: the principles on which the whole system rests.
• Materia medica describes the symptoms and characteristics attributed to each medicine: physical symptoms, emotional features, what makes the person better or worse (modalities), sleep, appetite, thirst and so on.
• Repertories work in the opposite direction. They begin with a symptom and list the medicines associated with it in the literature.
• Homeopathic pharmacy sets out how each medicine is to be prepared: identification of starting materials, mother tinctures, trituration, dilution and succussion, potency scales, dosage forms, dispensing and storage.

Homeopathic philosophy is taught as a core subject in every homeopathic course, often alongside the Organon; in India’s BHMS curriculum, for example, it is taught together with the Organon of Medicine as a core subject of the degree. It covers the principles that guide practice:

• the law of similars, the single remedy and the minimum dose
• individualisation and the totality of symptoms
• the vital force, health, disease and susceptibility
• the theory of chronic disease and miasms
• case-taking, case analysis and evaluation of symptoms
• potency selection, repetition of doses and remedy relationships
• the direction of cure and the assessment of progress

Alongside Hahnemann’s Organon, the classic philosophy texts include Kent’s Lectures on Homoeopathic Philosophy (1900), Stuart Close’s The Genius of Homoeopathy (1924) and Herbert A. Roberts’s The Principles and Art of Cure by Homoeopathy (1936). Philosophy links the other branches of the literature together: it explains why a remedy is chosen from the materia medica and repertory in the way it is, and why the pharmacy prepares it as it does.

For example, a practitioner investigating a headache made worse by sunlight might look up that symptom in a repertory, note the candidate remedies, and then compare their fuller descriptions in the materia medica.

Bönninghausen’s repertory gave particular attention to location, sensation, modalities and accompanying symptoms. Kent’s repertory organised symptoms into extensive sections and became the standard reference of classical prescribing. Boger later combined characteristic symptoms with causation, timing and pathology.

Modern computer repertories allow practitioners to search these records quickly and consistently. They make analysis faster and more consistent, while the quality of each result still depends on the provings and clinical reports behind it. The literature draws on several sources, including provings, toxicology and clinical experience, and practitioners often weigh entries according to their source.

Homeopathic pharmacy has been part of the system from the start. Hahnemann was himself a skilled chemist and pharmacist, and the Organon gives detailed instructions on preparing and potentising medicines. Specialist pharmacy works followed, including Willmar Schwabe’s multilingual Pharmacopoea Homoeopathica Polyglottica (1872), Boericke and Tafel’s American Homoeopathic Pharmacopoeia (1882), and the official national pharmacopoeias described in Part III, such as the German HAB, the HPUS and the Homoeopathic Pharmacopoeia of India. Homeopathic pharmacy is taught as a core subject in homeopathic medical education, including India’s BHMS degree, so that practitioners understand how the medicines they prescribe are made, labelled and stored.

Provings: how homeopathic medicines are tested

A proving (from the German Prüfung, a test) is the systematic administration of a substance to healthy volunteers in order to record the symptoms it produces. Provings are the foundation of the materia medica: according to the law of similars, the symptoms a substance produces in the healthy are the guide to the symptoms it can relieve in the sick.

Hahnemann’s method

Hahnemann set out his rules for provings in Aphorisms 105 to 145 of the Organon. He required that:

• provers be healthy, reliable and observant people of both sexes, living a moderate lifestyle
• only one substance be tested at a time, in a pure and well-identified form
• provers avoid other medicines, stimulants and unusual foods or activities during the proving
• every change in body and mind be recorded precisely, with its time, location, sensation and the circumstances that made it better or worse

Hahnemann first proved substances in material doses, and later, in the fifth and sixth editions of the Organon (Aphorism 128), recommended the 30C potency for provings, believing it brought out the medicine’s fuller range of action. He proved many medicines on himself, his family and his students.

How a modern proving is carried out

Modern provings follow written protocols, such as those published by the European Committee for Homeopathy, and usually include:

Stage	What happens
Organisation	A proving director oversees the study, supported by supervisors who each follow a small group of provers. Ethical approval and informed consent are obtained
Selection of provers	Typically 10 to 50 healthy adult volunteers, often around 15 to 30, screened by medical history and examination
Blinding and placebo	The substance is coded so that neither provers nor supervisors know what is being tested; a proportion of provers, often 10 to 30%, receive placebo for comparison
Baseline period	Provers record their normal state for one to two weeks before taking the substance, so that pre-existing symptoms can be identified
Dosing	Commonly 30C, and sometimes 6C, 12C or 200C, with different groups sometimes taking different potencies. Doses are taken, for example, up to three times a day for a short period, and stopped as soon as clear symptoms appear
Recording	Each prover keeps a daily diary of every symptom, with its time, location, sensation, modalities and accompanying symptoms, including mental and emotional changes and dreams. Supervisors interview provers regularly, often daily at first
Follow-up	Observation continues for several weeks or months after the last dose, until symptoms have subsided
Evaluation	Symptoms are classified as new, old symptoms returning, altered or relieved, and those explained by other causes or also seen in the placebo group are set aside

From proving to materia medica

Once a proving is complete, its symptoms are turned into a materia medica entry:

1. Collation. The confirmed symptoms from all provers are gathered, preserving the provers’ own words where possible.
2. Arrangement. Symptoms are arranged in Hahnemann’s traditional head-to-foot scheme: mind, vertigo, head, eyes, ears, nose, face, mouth and so on through the body, followed by sleep, dreams, fever, skin and generalities.
3. Grading. Symptoms are weighted by how many provers experienced them and how strongly, traditionally shown in print by type style (plain, italics, bold or capitals).
4. Adding other sources. The proving picture is combined with toxicology (effects of poisoning or overdose) and, over time, with clinical symptoms that have repeatedly improved in patients treated with the remedy.
5. Synthesis. Authors then distil the “drug picture”: the remedy’s characteristic keynotes, its mental and emotional state, its general features (such as reactions to heat, cold, time of day or food) and its modalities.
6. Entry into the repertory. Each symptom is translated into a repertory rubric, so that it can be found by practitioners searching from the patient’s symptoms.

This is how the great works of materia medica were built: Hahnemann’s Materia Medica Pura and The Chronic Diseases from his provings, T. F. Allen’s Encyclopedia of Pure Materia Medica and Hering’s Guiding Symptoms from collected provings and clinical confirmations, and concise works such as Boericke’s Pocket Manual from the most characteristic features of each remedy.

Polychrests and remedy trios

Two traditional ways of organising the materia medica help practitioners learn and compare remedies: polychrests, the broadest and most frequently used medicines, and trios, groups of three remedies that share a prominent feature.

Polychrest remedies

The word polychrest comes from the Greek polychrestos, “useful for many things”. The term was used in pharmacy before Hahnemann, and he applied it to medicines whose provings produced an exceptionally wide range of symptoms, describing Nux vomica, for example, as a polychrest in his Materia Medica Pura. Polychrests are sometimes called the “great remedies” or “major medicines”.

Polychrests have three features in common:

• A broad sphere of action: they affect many organs and systems as well as the mind and emotions.
• A rich, well-verified picture: extensive provings and two centuries of clinical confirmation.
• Frequent use: they appear in a large number of repertory rubrics, and many correspond to common constitutional types.

Remedies widely regarded as polychrests include Sulphur, Calcarea carbonica, Lycopodium, Natrum muriaticum, Pulsatilla, Sepia, Phosphorus, Nux vomica, Arsenicum album, Lachesis, Silicea, Belladonna, Bryonia and Rhus toxicodendron. Students usually learn these first, because they form the core of everyday practice. Teachers also stress the value of the so-called small remedies, which have narrower but distinctive pictures, so that a well-indicated smaller remedy is not overlooked in favour of a familiar polychrest.

Remedy trios

A trio is a group of three remedies that share a strong common feature, such as restlessness or constipation, but differ in their characteristic details. The approach is especially associated with the American homeopath E. B. Nash, who compared remedies in this way in his Leaders in Homoeopathic Therapeutics (1898), and trios are widely taught in homeopathic courses, particularly in India.

Trios are used as a learning and differentiation tool rather than as fixed prescriptions. When a patient shows the shared feature, the practitioner compares the three remedies’ modalities, sensations and accompanying symptoms to see which matches best, while still considering the whole case. Some classic trios are:

Trio	Shared feature	How the three are distinguished in the materia medica
Aconite, Arsenicum album, Rhus toxicodendron	Restlessness	Aconite: sudden, intense acute states with great fear. Arsenicum: anxious restlessness with exhaustion and burning pains, often worse after midnight. Rhus tox: physical restlessness from stiffness, better from continued motion
Alumina, Bryonia, Opium	Constipation	Alumina: inactive rectum, with difficulty even with soft stool. Bryonia: large, dry, hard stools, as if burnt. Opium: no urge at all, with small hard balls and general sluggishness
Aloe, Podophyllum, Sulphur	Early-morning diarrhoea	Aloe: urgency and a sense of insecurity in the rectum. Podophyllum: profuse, gushing, painless stools. Sulphur: diarrhoea that drives the person out of bed early in the morning

A related idea is the remedy cycle or sequence, the best known being Sulphur, Calcarea carbonica and Lycopodium, which Hahnemann’s successors observed often follow one another well in chronic cases. Like trios, it reflects the long tradition of studying remedies in relation to each other.

The theory of miasms

The theory of miasms is Hahnemann’s explanation of chronic disease, and it remains one of the central ideas of classical homeopathy.

Origins

Hahnemann observed over many years that some chronic cases improved under well-chosen remedies but later relapsed or developed new complaints. He concluded that a deeper, underlying disease tendency was at work. After about twelve years of study he set out his theory in The Chronic Diseases (1828), calling these underlying tendencies miasms, from the Greek word for a taint or pollution. In his view, treating the miasm, and not only the presenting symptoms, was the key to lasting cure in chronic illness.

Hahnemann’s three miasms

Miasm	Hahnemann’s association	Characteristic tendencies described in homeopathic literature	Remedies traditionally associated
Psora	Suppressed itch-like skin eruptions; regarded as the oldest and most fundamental miasm, underlying most chronic disease	Functional disturbances, hypersensitivity, itching, dryness, anxiety and periodic complaints	Sulphur, Calcarea carbonica, Lycopodium, Psorinum
Sycosis	Suppressed gonorrhoea and “fig-wart” disease	Excess and overgrowth: warts, growths, catarrhs, fluid retention, and a tendency to secretiveness	Thuja, Medorrhinum, Natrum sulphuricum
Syphilis	Suppressed syphilitic infection	Destruction and degeneration: ulceration, bone and tissue changes, and despair	Mercurius, Aurum metallicum, Syphilinum

Later developments

Later homeopaths extended and reinterpreted the theory:

• J. H. Allen gave the most detailed classical account in The Chronic Miasms (1908) and described a “pseudo-psoric” or tubercular state combining features of psora and syphilis.
• The cancer miasm was proposed in the twentieth century, associated with the remedy Carcinosinum and the work of British homeopaths such as Donald Foubister.
• Modern Indian authors, including Subrata Kumar Banerjea, developed systematic methods of miasmatic diagnosis that are widely taught.
• Rajan Sankaran proposed an expanded scheme of ten miasms, each representing a characteristic pace and intensity of illness.

Miasms in practice today

Practitioners use miasmatic analysis to understand the deeper pattern of a chronic case, to interpret family and personal history, to explain recurring or alternating complaints, and to choose remedies, including nosodes, that address the underlying tendency as well as the current symptoms. Interpretations differ: some practitioners follow Hahnemann’s original infectious explanation closely, while many now understand miasms as inherited or acquired patterns of susceptibility. Miasms are a concept within homeopathic philosophy rather than conventional pathology, and they remain a core part of homeopathic education, particularly in India.

Different schools and branches of homeopathy

Homeopathy gradually developed into several distinct approaches. Patients may meet any of them, sometimes without realising which one their practitioner follows, so it is reasonable to ask.

Approach	What it involves	Where you might meet it
Classical	One remedy at a time, chosen on the totality of characteristic symptoms; the aim is the simillimum, the closest match	Many individual practitioners, especially in the UK, US and India
Complex or combination	Several homeopathic ingredients in one product, aimed at a symptom, organ or condition	Over-the-counter products, especially in continental Europe
Pluralist	More than one remedy, separately or in sequence, with some individualisation	Some practitioners in France and elsewhere
Clinical	Remedy chosen mainly by diagnosis or presenting complaint	Acute self-care; some medically qualified homeopaths
Constitutional	Remedy chosen on the person’s broader temperament, physical tendencies and recurring patterns	Classical practice influenced by Kent
Isopathy	A preparation of the same substance thought to cause the problem (for example, a pollen preparation for hay fever)	Some practitioners; conceptually distinct from “like cures like”

Nosodes are preparations made from disease material, microorganisms or other biological sources. Their manufacture requires controls for biological hazards. Nosodes are not vaccines. They are not designed or authorised as vaccines, and UK homeopathy registers, including the Faculty of Homeopathy and the Society of Homeopaths, have stated that they do not endorse homeopathy as an alternative to vaccination.

Sarcodes are preparations derived from healthy tissues, organs or physiological substances. They are used according to homeopathic principles and are distinct from conventional hormone or biological therapies.

Related traditions

• Electrohomeopathy, developed by Count Cesare Mattei in nineteenth-century Italy, uses complex botanical preparations and departs from several central features of Hahnemann’s system. It has nothing to do with electrical medical treatment.
• Schüssler tissue salts, developed by the German physician Wilhelm Heinrich Schüssler, use twelve principal mineral salts, usually in low decimal potencies, on the theory that disturbances of these salts contribute to disease.
• Homotoxicology, associated with Hans-Heinrich Reckeweg, links illness to the body’s response to harmful substances and promotes complex and “bioregulatory” preparations.

Each of these traditions has its own literature, training and following.

Two terms cause frequent confusion. Bioregulatory medicine is sometimes used loosely in complementary medicine, but conventional biological medicines (vaccines, monoclonal antibodies, therapeutic proteins) are scientifically and legally quite different from homeopathic products. Likewise, “low-dose medicine” can describe products that contain measurable active substances, or ones prepared by homeopathic dilution that contain none. Patients should not assume the two are equivalent.

Edward Bach and flower remedies

Edward Bach (1886–1936) was a British physician, bacteriologist and pathologist who later took up homeopathy. His early work on intestinal bacteria led to preparations known as the Bach bowel nosodes.

Bach came to place increasing importance on emotional states and personality. Between the late 1920s and his death in 1936 he developed a system of 38 flower remedies, each associated with a particular emotional state: for example, Mimulus for known fears, Aspen for vague fears of unknown origin, and Walnut for adjusting to change. The combination later sold as Rescue Remedy brings together five of them. He set out his ideas in Heal Thyself and The Twelve Healers and Other Remedies.

The remedies were made by steeping flowers in water in sunlight, or by boiling plant material, then preserving the liquid (traditionally in brandy) and diluting it. Bach’s mature system did not use Hahnemannian potentisation or symptom similarity; it is a distinct tradition centred on emotional states.

Two points for users: the stock remedies contain alcohol, which matters for children, pregnancy, people avoiding alcohol and some medicines; and many users report finding them helpful, particularly at times of stress or change. People with persistent anxiety or low mood may also benefit from medical assessment.

How the great homeopaths took a case

Homeopathic case-taking was not meant to be a collection of personal impressions. Hahnemann set out a systematic method in Aphorisms 83 to 104 of the Organon, and later practitioners developed different ways of analysing what they gathered.

Hahnemann’s method. In Aphorism 84 he instructed the physician to let patients describe their complaints in their own words, recording what they said and observing their behaviour. He discouraged interruption and leading questions. In the following aphorisms he described how to clarify symptoms, investigate their circumstances and separate what the patient reports spontaneously from what is obtained by questioning. For chronic cases he gave weight to occupation, habits, diet, living conditions, previous illnesses and treatments, and anything maintaining the illness. Aphorism 153 gave special importance to symptoms that are “striking, singular, uncommon and peculiar” rather than those common to many illnesses.

Later approaches emphasised different things:

• Bönninghausen: an analytical method built on the location of a symptom, its sensation, its modalities and its accompanying symptoms.
• Kent: mental and emotional characteristics, general physical tendencies and a hierarchy of symptoms, used to select a constitutional remedy.
• Boger: symptom analysis combined with causation, timing, modalities and pathological tendencies.

The traditional sequence was: take the history, identify the most characteristic symptoms, consult the repertory, compare candidate remedies in the materia medica, choose the medicine, then review changes at follow-up.

The unhurried, attentive listening at the heart of this method is one of homeopathy’s most valued features for patients, and something conventional medicine has sometimes learned from. Many practitioners combine it with conventional clinical assessment.

Matching the remedy to the patient

The heart of homeopathic prescribing is matching the patient’s symptoms with the symptoms recorded for a remedy in provings and clinical experience. This is usually done in five steps.

1. Evaluating the symptoms. Not all symptoms carry equal weight. Following Hahnemann’s Aphorism 153 and Kent’s hierarchy, practitioners usually rank them as follows:

Type of symptom	Examples	Weight in prescribing
Characteristic, strange, rare and peculiar	Burning pains relieved by heat; no thirst during a high fever; feeling better while moving despite pain	Highest
Mental and emotional	Grief, fears, irritability, need for company or solitude	High
Physical generals (the whole person)	Reaction to heat and cold, appetite, thirst, food cravings and aversions, sleep, perspiration	High
Particular symptoms with full detail	A local complaint described by location, sensation, modalities and accompanying symptoms	Moderate
Common symptoms of the disease	Symptoms shared by most people with the same condition, such as fever in influenza	Low

2. Repertorisation. The selected symptoms are translated into repertory rubrics, and the remedies listed under each rubric are compared. Practitioners may use Kent’s totality approach, Bönninghausen’s method of combining location, sensation, modality and concomitant, or an eliminative approach that starts from the single most characteristic rubric. This can be done by hand or with repertory software, which scores remedies by how many rubrics they appear in and at what grade.

3. Comparison in the materia medica. The highest-scoring remedies are not chosen automatically. The practitioner reads each candidate’s full picture in the materia medica and compares it with the patient as a whole, especially the characteristic, mental and general symptoms. The remedy that matches most closely is the simillimum.

4. Final selection. The practitioner also considers the miasmatic background, the patient’s constitution, any previous remedies and known remedy relationships, and then chooses the potency and dosing.

5. Follow-up. The patient’s response is assessed at the next consultation, and the remedy, potency or dosing is continued, adjusted or changed accordingly.

A teaching example. A classic textbook illustration describes a person with a headache that is worse from the slightest movement and better from firm pressure and lying perfectly still, with great thirst for large drinks of cold water, and irritability with a wish to be left alone. These symptoms correspond to repertory rubrics such as “Head, pain, motion aggravates”, “Head, pain, pressure ameliorates”, “Stomach, thirst, large quantities” and “Mind, irritability, wants to be alone”, all of which feature the remedy Bryonia in the traditional literature. The example shows the method of matching rather than a recommendation for any individual.

Modern practice. Professional standards for homeopathic consultations today also commonly include:

1. Asking whether the person has a medical diagnosis, and from whom.
2. Recording all current medicines and supplements, and never advising that prescribed treatment be stopped or changed.
3. Screening for red-flag symptoms that need urgent or prompt medical assessment.
4. Knowing the limits of one’s own training, and referring when needed.
5. Recording what was advised and agreeing when the person will seek medical review if they do not improve.

How Hahnemann, Kent and others selected potencies

Potency selection became one of the most debated subjects in homeopathy, and there has never been one agreed rule.

• Hahnemann moved over his career towards smaller doses and centesimal potencies. His fifth edition of the Organon generally advised against repeating a remedy while improvement continued. In the sixth edition (especially Aphorisms 246 to 248) he described repeated doses in solution, each slightly modified by succussion, and introduced LM potencies, partly to allow repetition while reducing aggravation.
• Kent became associated with high centesimal potencies (30C, 200C, 1M and above), single remedies, and careful waiting and observation after a dose. His choice of potency depended on his view of the patient’s susceptibility, how well the remedy matched, the nature of the illness and the response to earlier doses.
• Hering contributed to prescribing traditions across a range of potencies but did not establish a numerical rule.
• Bönninghausen and Boger concentrated more on symptom analysis and remedy selection than on a fixed potency schedule.
• Later clinical schools often favoured low decimal and centesimal potencies for local or organ-related complaints, while classical practitioners tended to use higher potencies for constitutional prescribing.

Practitioners have weighed factors such as the patient’s perceived sensitivity, whether the illness is acute or chronic, how closely the remedy matches, previous reactions and progress after each dose. These remain matters of clinical judgement developed over two centuries of practice.

Hering’s law, aggravation and recovery

The “direction of cure”. Hering’s name is attached to a traditional theory that healing proceeds from within outwards, from above downwards, from more important organs to less important ones, and in the reverse order in which symptoms appeared. The familiar four-part formulation was largely systematised by later authors, notably Kent, from ideas found in Hering and Hahnemann. It remains a central teaching that many practitioners use to assess progress.

Homeopathic aggravation is a temporary worsening of symptoms sometimes observed after a remedy, which practitioners have traditionally interpreted as a sign that the remedy is acting.

Worsening can also have other causes: the illness may be progressing, there may be a reaction to something else, the diagnosis may be different, or the remedy may not suit the patient. For this reason, both homeopathic teaching and conventional medicine regard significant, prolonged or worrying worsening as something to be medically assessed rather than assumed to be part of recovery.

Practitioners therefore assess progress through the overall picture: symptoms improving, energy and function returning, objective findings where relevant, and the patient’s general sense of wellbeing.

Part III: Homeopathic medicines and manufacture

How remedies are made and labelled, the forms they come in, and the pharmacopoeial and GMP standards that control their quality.

How homeopathic medicines are prepared

Homeopathic pharmacy developed its own methods.

Starting materials may come from plants, minerals, chemicals, animals or biological sources. Their identity, purity, origin and suitability must be established according to the applicable pharmaceutical standards.

Plant materials are often extracted into mother tinctures, marked Ø or Q. Soluble substances may be made into solutions, while insoluble materials are first ground (triturated) with lactose or another carrier.

A mother tincture is not a highly diluted preparation. It can contain measurable amounts of active constituents and can therefore cause pharmacological or toxic effects. The same applies to low potencies of toxic starting materials, such as some plant and mineral sources.

Potentisation is the process of repeated dilution with vigorous shaking (succussion) at each step, or repeated trituration for solids. In homeopathic theory this develops medicinal potency. How potentisation works continues to be investigated by homeopathic researchers.

Reading potency notation

Notation	Meaning	Each step	Example	Nominal dilution
Ø or Q	Mother tincture	—	Calendula Ø	Undiluted extract
X or D	Decimal scale	1 in 10	6X / D6	1 in 1,000,000
C or CH	Centesimal, Hahnemannian (separate vessels)	1 in 100	6C	1 in 10¹²
C or CH	Centesimal	1 in 100	12C	1 in 10²⁴
C or CH	Centesimal	1 in 100	30C	1 in 10⁶⁰
K or CK	Korsakovian (single vessel emptied and refilled)	approx. 1 in 100	30K	Not directly comparable to 30C
LM or Q	Fifty-millesimal scale	1 in 50,000 (nominal)	LM1	Distinctive multi-stage method
M, 10M, CM	1,000C, 10,000C, 100,000C	1 in 100	1M	1 in 10²⁰⁰⁰

Note that “Q” is used both for mother tinctures and for LM potencies, depending on the tradition and country, so it is worth checking which is meant on a label.

These symbols describe how a preparation was made, not the strength of a pharmacological dose. Why homeopaths potentise, and what the “Avogadro limit” means, are explained in the next section.

A practical consequence for patients: a higher potency number does not mean a stronger medicine in the conventional sense, and a low potency or mother tincture is not automatically safer because it is “homeopathic”.

Why potentise? Dynamisation, succussion and the Avogadro limit

Why Hahnemann began diluting

Hahnemann first diluted his medicines for a practical reason: many of the substances he used, such as arsenic, mercury and belladonna, were toxic in material doses, and even well-chosen remedies could cause severe initial aggravations. Diluting them made treatment safer. He then reported a surprising observation: when each dilution step was accompanied by vigorous shaking, the medicines did not lose their healing power as dilution increased, but seemed to act more deeply and gently. He called this process dynamisation or potentisation.

From material substance to dynamic power

Hahnemann’s explanation follows from his philosophy of health and disease. In the Organon (Aphorisms 9 to 16) he described the vital force as a dynamic, non-material principle, and disease as a dynamic disturbance of it. He reasoned that a medicine must act on the same dynamic level in order to restore it. In Aphorisms 269 to 271 he wrote that potentisation releases and develops the “spirit-like” (geistartig) medicinal power that lies hidden, or latent, in a crude substance. In homeopathic terms, the inherent, mostly inactive energy of the raw material is transformed into an active, dynamic medicinal energy.

Homeopaths point to two observations in support of this view:

• Inert substances become medicines. Substances with little action in their crude state, such as Lycopodium spores, silica (flint) and common salt, are among the most widely used remedies once triturated and potentised.
• Higher potencies act more deeply. In clinical experience, homeopaths report that higher potencies tend to act more on the mental, emotional and constitutional level, and lower potencies more on local and physical complaints.

Succussion and trituration

Succussion is the forceful downward shaking of the vial, striking it against a firm but elastic surface; Hahnemann traditionally used a leather-bound book. In his earlier practice he recommended a small number of strokes per step, and in the sixth edition of the Organon, for LM potencies, 100 strokes. Homeopaths regard succussion, not dilution alone, as the essential step: dilution without succussion is said to produce only a weaker solution, while succussion imparts the medicinal energy to the carrier. Trituration, prolonged grinding with lactose in a mortar, plays the same role for insoluble substances: Hahnemann described about an hour of grinding for each of the first three centesimal steps, after which the material can be dissolved and potentised further in liquid.

The Avogadro limit explained

The Avogadro constant, about 6.022 × 10²³, is the number of molecules in one mole of a substance; one mole of common salt, for example, weighs about 58 grams. Because each centesimal step dilutes the original material a hundredfold, the number of original molecules falls very quickly. Starting, for illustration, from a full mole of substance:

Potency	Total dilution	Molecules of the original substance expected to remain
3C	1 in 10⁶	About 6 × 10¹⁷
6C	1 in 10¹²	About 6 × 10¹¹
9C	1 in 10¹⁸	About 600,000
12C	1 in 10²⁴	Less than one
30C	1 in 10⁶⁰	Effectively none: to expect a single molecule, one would need a volume of liquid more than a billion times the volume of the Earth

The point at which, on average, no molecule of the original substance is expected to remain, around 12C (or about 24X), is called the Avogadro limit. Because most mother tinctures contain far less than a mole of active substance, the limit is often reached a few steps earlier in practice. Potencies below it, such as 6C or 6X, still contain measurable amounts of the starting material.

Theoretical limit versus practical reality. The Avogadro limit is a calculation that assumes every dilution step is perfect. In real manufacture, molecules and particles can cling to the walls of vials and be carried forward from one step to the next, particularly in the Korsakovian single-vessel method. Some studies, such as Chikramane and colleagues (2010), have reported detecting nanoparticles of the original metals in preparations as high as 30C and 200C. A laboratory result of “not detected” also means only that any remaining material is below the instrument’s limit of detection, not that its absence has been proven. Homeopathic researchers therefore argue that traces of the starting material may persist beyond the theoretical limit. These findings are still debated and await wider independent replication, and the same carry-over that could retain the starting substance could also retain impurities from solvents and containers, which is one reason GMP controls on materials and equipment matter.

How do potencies above the Avogadro limit act?

For Hahnemann the question did not arise in the same way, because he understood the medicine’s action as dynamic rather than material. Modern homeopathic researchers have proposed several explanations for how high potencies might carry information from the original substance, including:

• Structural changes in the solvent, sometimes described as the “memory of water”, in which succussion is thought to leave lasting changes in the arrangement of water molecules.
• Nanoparticles, following studies such as Chikramane and colleagues (2010), which reported nanoparticles of the starting metals in commercial high-potency preparations.
• Physical and energetic properties studied with methods such as thermoluminescence and spectroscopy.

These remain hypotheses under active investigation. Mainstream chemistry and physics have not accepted a mechanism by which preparations beyond the Avogadro limit could act, and this is one of the central points in the wider scientific debate about homeopathy described in Part IV.

Forms of homeopathic medicines

Homeopathic preparations are supplied in several forms:

• Oral: globules (pills), tablets, powders, drops and solutions.
• External: creams, gels, ointments, sprays and other topical products. Some topical products, such as arnica creams, are low potencies or tinctures and contain measurable plant material, so skin reactions are possible and they should not be applied to broken skin unless the label allows.
• Injectable: available in some markets as homeopathic or “bioregulatory” preparations.

The route of administration changes both the risks and the regulatory requirements. An oral globule is not equivalent to an injection. Injection bypasses the body’s protective barriers and introduces risks of contamination, infection, tissue injury and reactions to the injected material.

Biopuncture refers to injecting low-dose or homeopathic preparations into selected tissues or points. Like any injection, it requires appropriate hygiene and training.

Medical devices are sometimes marketed alongside homeopathic treatments. Their legal classification depends on their intended purpose and mode of action; a device is not a homeopathic medicine just because a homeopath uses it.

The range of forms shows how far the modern industry has moved beyond the original practice of individualised oral remedies.

Pharmacopoeias, quality and GMP

As homeopathy spread, consistent pharmaceutical preparation became increasingly important. Several pharmacopoeias set out standards:

• German Homoeopathic Pharmacopoeia (HAB): detailed manufacturing procedures and quality standards.
• European Pharmacopoeia: general monographs and methods for homeopathic stocks and finished preparations.
• British Homoeopathic Pharmacopoeia: first published in 1870 and historically influential; today the British Pharmacopoeia and recognised European or national standards apply under UK regulation.
• Homoeopathic Pharmacopoeia of the United States (HPUS).
• Homoeopathic Pharmacopoeia of India, the Brazilian Homeopathic Pharmacopoeia, and French national standards.

These pharmacopoeias are not automatically interchangeable. Their legal relevance depends on the country, the product’s classification, the manufacturing method and the applicable regulations. They may specify starting materials, extraction methods, solvents, dilution procedures, trituration, identification tests and quality standards.

Good Manufacturing Practice (GMP) provides the wider quality system within which preparations must be made: qualified staff, suitable premises, qualified equipment, controlled raw materials, documented procedures, contamination prevention, cleaning, in-process controls, testing, packaging, labelling, stability and traceability.

For example, making globules involves preparing the required dilution, applying it to pharmaceutical-grade sucrose or another carrier, controlling impregnation and drying, and filling the finished globules into suitable containers. The manufacturer must show the process is reproducible and that contamination and mix-ups are prevented.

Liquid preparations raise questions of solvent quality, ethanol content, water quality, microbiological risk and container compatibility. Injectable preparations demand much stricter controls: sterility assurance, particulate and endotoxin limits, controlled environments, and validated aseptic processing or sterilisation.

A pharmacopoeia describes recognised preparation and quality standards, and GMP is the system by which manufacturing is consistently controlled. Together they protect people from contaminated, mislabelled or wrongly prepared products. Questions of clinical effectiveness are considered separately, in Part IV.

GMP facilities: zones, cleanroom grades and ISO classes

Sterile homeopathic products (injectables, eye drops) must be made in classified cleanrooms graded A to D under GMP Annex 1. Non-sterile products (globules, tablets, oral drops, creams) have no legally fixed cleanroom grade, but must be made in controlled areas whose standard is justified by a documented risk assessment. In the UK, manufacturers hold an MHRA manufacturer’s licence and are inspected against UK GMP (the “Orange Guide”), which follows the EU GMP Guide, including the 2022 revision of Annex 1.

Types of area in a manufacturing facility

Area type	Particle-classified?	Typical controls	Examples in homeopathic manufacture
General (unclassified)	No	Access control, pest control, cleaning, temperature mapping where storage needs it, segregation of quarantine, released and rejected stock	Warehouse, offices, corridors outside production
Controlled not classified (CNC)	No	Filtered air supply, pressure cascade, temperature and humidity limits, defined cleaning and gowning, environmental monitoring set by risk	Weighing of closed containers, secondary packaging, storage of labelled stocks
Classified, Grade D (ISO 8 at rest)	Yes	HEPA-filtered air, pressure differentials, particle and microbial monitoring, Grade D gowning	Open handling of non-sterile product where risk assessment requires it; component handling for sterile lines
Classified, Grades C, B and A	Yes	Increasingly strict air, gowning, monitoring and aseptic practice	Sterile manufacture (see below)
Contained or segregated	Depends on process	Dedicated rooms and equipment, negative pressure or local extraction, biosafety controls, validated cleaning	Nosode starting materials from pathogenic sources; toxic stocks (for example arsenic, mercury or aconite compounds) at low potencies; sensitising materials

A “controlled” area is not a cleanroom. The term “uncontrolled” should be avoided in GMP documentation: every area used for medicines has some GMP controls, even if it is not particle-classified.

Cleanroom grades for sterile products (Annex 1, 2022)

Maximum airborne particles per cubic metre:

Grade	At rest, ≥0.5 µm	At rest, ≥5 µm	In operation, ≥0.5 µm	In operation, ≥5 µm	ISO 14644-1 class (at rest / in operation)
A	3,520	Not specified	3,520	Not specified	ISO 5 / ISO 5
B	3,520	Not specified	352,000	2,930	ISO 5 / ISO 7
C	352,000	2,930	3,520,000	29,300	ISO 7 / ISO 8
D	3,520,000	29,300	Set by the site’s risk assessment	Set by the site’s risk assessment	ISO 8 / defined by the contamination control strategy

Maximum microbial contamination:

Grade	Air sample (CFU/m³)	Settle plate, 90 mm (CFU/4 hours)	Contact plate, 55 mm (CFU/plate)	Glove print, 5 fingers (CFU/glove)
A	No growth	No growth	No growth	No growth
B	10	5	5	5
C	100	50	25	—
D	200	100	50	—

Typical use of each grade:

Grade	Aseptically prepared products	Terminally sterilised products
A	Aseptic filling and any open handling of sterile product (critical zone, unidirectional airflow)	Filling only where risk is unusually high
B	Background room for a Grade A zone (or a restricted-access barrier system)	Not normally needed
C	Preparation of solutions to be sterile-filtered	Filling of products before terminal sterilisation
D	Handling of components after washing; background for a closed isolator	Preparation of solutions and components

Other Annex 1 expectations include a site-wide contamination control strategy, requalification of Grade A and B areas at least every 6 months and Grade C and D areas at least every 12 months, pressure differentials between adjacent grades (commonly about 10 Pa), Water for Injections for parenteral products, and gowning that becomes stricter from Grade D to Grade A.

Non-sterile products

EU and UK GMP do not set a minimum cleanroom grade for non-sterile manufacture. Instead, the manufacturer must show that its controls prevent contamination and cross-contamination for that product and process. In practice:

• Open processing of exposed product (dilution and succussion, trituration, impregnating globules, filling oral liquids, making creams) is commonly done in CNC rooms or rooms built to a Grade D / ISO 8 standard, with HEPA-filtered supply air, a pressure cascade and defined gowning.
• Closed or low-risk steps (secondary packaging, storage of sealed containers) usually need only general GMP controls.
• Purified Water is the normal minimum for aqueous non-sterile preparations; ethanol-based dilutions carry lower microbial risk but still need controlled solvents and containers.
• Finished-product microbiological quality is tested against the European Pharmacopoeia general chapter 5.1.4. For example, aqueous oral preparations are typically limited to 10² CFU/g or mL total aerobic count and 10¹ yeasts and moulds, with absence of E. coli; non-aqueous oral preparations to 10³ and 10². Herbal-origin stocks may also fall under chapter 5.1.8. Manufacturers should check the current edition.

Why “no legal minimum” still leads to a controlled facility

GMP does not fix a grade for non-sterile manufacture, but it does fix the outcome: no contamination, cross-contamination or mix-ups, with the manufacturer responsible for proving it. The requirements in other GMP chapters together push the design towards a controlled facility:

• Starting materials and suppliers: supplier qualification and audits, identity and quality testing of each batch of mother tincture, stock or carrier, and controlled sampling so materials are not contaminated when opened.
• Premises and air: areas must allow effective cleaning and prevent contamination, which in practice means smooth cleanable surfaces, filtered air and pressure differentials between rooms.
• Exposure time: the longer product is open (during succussion, trituration, impregnation or drying), the more the environment matters. Hold-time and exposure studies are expected to justify the conditions.
• Contamination and mix-up control: segregation, line clearance, cleaning validation and dedicated equipment where needed, which matters especially when many identical-looking potencies are made in one room.
• Proof by data: environmental monitoring trends, bioburden results and finished-product testing against Ph. Eur. 5.1.4 must support whatever standard the site chose.
• Quality risk management (ICH Q9): the choice of room standard must be documented and justified in a risk assessment that an inspector can challenge.

The result is a self-justified standard. A manufacturer may defend a lower standard for closed processes or high-ethanol liquids. For open handling of exposed product, though, the simplest defensible position is usually a controlled-not-classified room or one built and monitored to a Grade D / ISO 8 standard.

The homeopathic-specific MHRA guidance on the manufacture and control of dosage forms, the HAB and the HPUS add requirements for potentisation equipment, separate vessels, labelling of stocks and prevention of mix-ups between potencies, which is a particular risk when many visually identical dilutions are made in the same room.

Part IV: Patient experience, research and safety

What patients and practitioners value in homeopathy, the research that supports it, the scientific debate, and safety considerations.

What patients and practitioners value

Homeopathy’s lasting popularity rests largely on what patients experience in practice. The features most often described are:

• The individual consultation: an unhurried appointment in which the patient is listened to in detail, often for an hour or more at a first visit, and treated as a whole person rather than as a diagnosis.
• Individualised treatment: remedies chosen for the patient’s particular pattern of symptoms, temperament and circumstances.
• Gentleness: homeopathic medicines are generally regarded as having a low risk of direct side effects, which many patients value.
• Affordability and accessibility: in countries such as India, homeopathy provides low-cost care through public dispensaries and hospitals, including in rural areas.
• Working alongside conventional care: many patients use homeopathy together with conventional medicine, and many practitioners are themselves medically qualified.
• Patient satisfaction: large observational studies, such as those at the Bristol Homeopathic Hospital and in Germany and Switzerland, have reported high satisfaction and improvement in patients’ self-reported health.

Research on homeopathy

Homeopathy has been studied in hundreds of clinical trials and many systematic reviews. Supporters point to a substantial body of positive research, while scientific opinion as a whole remains divided. Both are summarised below so readers can weigh them for themselves.

Research reporting positive effects

Supporters of homeopathy point to a substantial body of published research reporting positive results, including meta-analyses in mainstream journals. The most frequently cited are summarised below, with the limitations noted by their authors or by critics, so readers can judge them fairly.

Year	Study	Findings reported	Limitations noted
1991	Kleijnen et al., BMJ: review of 107 controlled trials	Most trials reported positive results; the authors said the evidence would be convincing for a treatment with a more plausible mechanism	Most trials were of low methodological quality
1997	Linde et al., The Lancet: meta-analysis of 89 placebo-controlled trials	Combined odds ratio 2.45 in favour of homeopathy (1.66 for 26 good-quality trials; 1.78 after correction for publication bias); concluded results were not compatible with effects being entirely placebo	The same authors found insufficient evidence that homeopathy was clearly effective for any single condition; their later reanalysis found smaller effects in higher-quality trials
2003	Jacobs et al., Pediatric Infectious Disease Journal: three randomised trials, 242 children with acute diarrhoea	Diarrhoea lasted 3.3 days with individualised homeopathy versus 4.1 days with placebo, alongside oral rehydration	Small trials; critics questioned comparability of groups
2005	Spence et al., Journal of Alternative and Complementary Medicine: 6,544 follow-up consultations at Bristol Homeopathic Hospital	About 70% of patients reported improvement in their health	Observational; no comparison group
2005	Witt et al., BMC Public Health: cohort of 3,981 patients in Germany and Switzerland	Marked and sustained reduction in symptom severity and improved quality of life over two years	Observational; no comparison group
2008	Lüdtke and Rutten, Journal of Clinical Epidemiology: reanalysis of the Shang 2005 data	The negative conclusion depended heavily on which subset of trials was analysed, and largely on one trial in marathon runners	Critics replied that any remaining benefit was clinically small
2014	Mathie et al., Systematic Reviews: 32 randomised trials of individualised homeopathy	Odds ratio 1.53 overall and 1.98 in the three most reliable trials; concluded remedies may have small, specific treatment effects	The authors judged overall evidence quality low or unclear and urged caution and new high-quality trials

Supporters also argue that:

• Standard trial designs struggle to test individualised prescribing, in which each patient may receive a different remedy.
• Reporting bias and outcome switching also affect conventional medical research at similar rates, so homeopathy should not be singled out.
• Some reviews concluding against homeopathy based their verdicts on small subsets of the available trials; homeopathy organisations have formally challenged the methods of the 2015 NHMRC review.
• Patient-reported outcomes, high satisfaction and reduced use of conventional drugs in some observational studies deserve weight in real-world healthcare decisions.

The scientific debate

Some major reviews and public bodies, including a 2005 meta-analysis in The Lancet (Shang et al.), the UK House of Commons Science and Technology Committee (2010) and Australia’s NHMRC (2015), concluded that the trial evidence did not show effects beyond placebo, and questioned how highly diluted remedies could act. Their methods have in turn been challenged by homeopathic researchers, for example over how trials were selected and which thresholds were applied. Both sides agree that further high-quality, independently replicated research would help resolve the question.

Safety considerations

Homeopathic medicines are generally regarded as having a low risk of direct side effects, particularly at higher potencies, and this is one reason many patients choose them. The safety points most often raised are:

• Use alongside medical care: health authorities and homeopathic professional bodies agree that homeopathy should not replace diagnosis, vaccination, or effective treatment for serious illness.
• Low potencies and mother tinctures: these can contain measurable active substances, so labels and dosing instructions matter.
• Product quality: alcohol content, carriers such as lactose, and manufacture to GMP standards (see Part III); injectable products carry the general risks of any injection.

Part V: Professional practice and regulation

Standards for practitioners, the UK legal framework for products, advertising and manufacture, and an overview of regulation in other countries.

Professional standards in homeopathic practice

Homeopathic professional bodies publish codes of ethics and practice for their members. The main themes they share are summarised below.

Ethics and scope of practice

• Informed consent: explaining what homeopathy involves, the likely number and cost of appointments, and how the evidence base is viewed.
• Scope of practice: working within one’s training, recognising symptoms that need medical assessment, and having a referral route.
• Prescribed treatment and vaccination: professional codes generally state that practitioners should not advise patients to stop prescribed medicines, and should direct vaccination questions to the patient’s GP, nurse or pharmacist.
• Children and vulnerable adults: additional attention to consent and safeguarding.
• Records, insurance and complaints: clear case records, professional indemnity insurance and a complaints procedure.

Working with conventional care

Many practitioners ask about each patient’s diagnosis, GP and current medicines and supplements, and, with consent, keep the GP informed. Suspected side effects of homeopathic products can be reported through the MHRA Yellow Card scheme, as for any medicine.

Advertising in the UK

Advertising by practitioners is overseen by the Advertising Standards Authority (ASA) under the CAP Code. The ASA’s published guidance distinguishes between:

• Claims it generally accepts: the history and theory of homeopathy, what a consultation involves, qualifications and memberships, and general statements such as that some clients find consultations calming.
• Claims it does not accept without robust clinical evidence: that homeopathy treats, cures or relieves specific medical conditions, testimonials implying such effects, and claims that might discourage people from seeking essential medical treatment or vaccination.

Product advertising is controlled separately by the MHRA: HR-registered products carry no indications, and NR products may state only the indications in their authorisation.

Research

Homeopathic researchers and professional bodies increasingly emphasise prospective trial registration, publication of all results, validated outcome measures, collaboration with independent academic researchers, and systematic recording of outcomes in everyday practice.

Continuing professional development

Professional bodies typically expect members to keep up to date with homeopathic literature and with first aid, safeguarding, medicines interactions, data protection and regulatory changes.

Regulation in the United Kingdom

Homeopathic medicinal products in the UK are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) under the Human Medicines Regulations 2012, through two schemes. Since 2025 both are authorised on a UK-wide basis, including Northern Ireland under the Windsor Framework.

	Simplified Homeopathic Registration Scheme	Homeopathic National Rules Scheme
Number on the pack	HR	NR
Routes allowed	Oral or external only; no injections	Any pharmaceutical form, provided quality requirements are met
Dilution	Must be dilute enough to guarantee safety (in general, no more than 1 part in 10,000 of the mother tincture)	No fixed minimum dilution; safety must be demonstrated
Indications	None. The label must state that it is a homeopathic medicinal product without approved therapeutic indications	May name minor symptoms or conditions for which it is used within the UK homeopathic tradition, which do not require medical supervision
Evidence submitted	Pharmaceutical quality and safety data	Quality and safety data plus evidence of traditional homeopathic use; rigorous clinical trial data is not required

What an NR indication means. An NR authorisation confirms that a product is of acceptable quality and safety and has a recognised history of use within UK homeopathy. It does not mean the MHRA has assessed it as clinically effective in the way it assesses conventional medicines.

Products outside both schemes. Homeopathic products that are neither registered nor authorised may only be sold or supplied if a specific legal exemption applies, for example certain preparations made up by a pharmacy for an individual patient. Unlicensed products may not be advertised to the public.

Advertising. Medicines advertising is controlled by the MHRA (see its Blue Guide), and advertising of homeopathic services by the ASA under the CAP Code (see “Professional standards in homeopathic practice”).

Manufacture. Manufacturers need an MHRA manufacturer’s licence and must follow UK GMP, including the cleanroom requirements described in “GMP facilities” for sterile products.

Practitioners. Homeopathy is not a statutorily regulated profession in the UK. Health professionals who practise it remain bound by their own regulator; others may join voluntary professional bodies.

The NHS. Since 2017 NHS England has advised that homeopathy should not be initiated for new patients in primary care, and NICE does not recommend it for any condition. NHS provision has largely ended.

How to read a UK homeopathic label

1. Look for HR or NR followed by a number. No number may mean an unlicensed product.
2. HR products: expect the phrase “without approved therapeutic indications” and no named condition.
3. NR products: any condition named should be minor and not need medical supervision.
4. Check the potency, the ingredients (including alcohol, lactose or sucrose), the batch number and the expiry date.
5. Report any suspected side effect through the MHRA Yellow Card scheme.

Regulation in other countries

The rules for homeopathic medicines, practitioners and advertising differ from country to country. The UK framework above is one example. Some other major systems are summarised below; readers should always check the current rules where they live.

Country or region	How homeopathic medicines are regulated
European Union	EU medicines law (Directive 2001/83/EC) provides a simplified registration procedure for sufficiently dilute oral and external products without therapeutic indications, and allows member states to keep national rules for others. Practitioner regulation varies by country
United States	Homeopathic products are drugs under the Federal Food, Drug, and Cosmetic Act, with the HPUS as an official compendium. The FDA applies a risk-based approach to their oversight (2022 guidance), and the Federal Trade Commission expects health claims for over-the-counter homeopathic products to be supported by the same standard of evidence as other health claims (2016 policy statement)
India	Homoeopathic medicines are regulated under the Drugs and Cosmetics Act and Rules and the Homoeopathic Pharmacopoeia of India; education and practitioner registration are governed by the National Commission for Homoeopathy under the Ministry of Ayush
Canada	Homeopathic medicines are regulated by Health Canada as natural health products and require a product licence before sale
Switzerland	Homeopathic medicines are authorised by Swissmedic, and physician-delivered homeopathy is covered by basic health insurance

In many countries, advertising of medicines and health services is restricted, and claims that a product or therapy treats a specific disease generally require evidence acceptable to the relevant authority.

Conclusion

Homeopathy began as a reaction against the harmful medicine of the eighteenth century and grew into a complete medical system with its own philosophy, literature, pharmacy, institutions and schools. Its history shows real intellectual effort, genuine care for patients, and a pharmaceutical tradition that today meets recognised quality standards.

Homeopathy’s endurance over more than two centuries, its place in national health systems from India to Switzerland and Brazil, and the loyalty of the many patients who value it make it one of the most significant traditions in the history of medicine. Scientific debate about how its remedies act continues, and supporters and critics alike agree that more high-quality research would help to answer it.

For patients, whatever their view, the safest course is to use homeopathy alongside, and never instead of, medical care for serious or uncertain illness. For practitioners, it is to combine respect for their tradition with openness about the evidence, careful safety-netting and close cooperation with conventional healthcare. For the wider community, it is to keep asking good questions and to support high-quality research that can answer them. Those commitments serve everyone who cares about patients’ wellbeing.

Disclaimer

This article is published for general information and educational purposes only. It does not constitute medical, pharmaceutical, legal or regulatory advice, and it is not intended to diagnose, treat, cure or prevent any disease or condition.

• Not a substitute for professional care. Readers should consult a qualified healthcare professional about any health concern, before starting or changing any treatment, and before stopping or altering any prescribed medicine. Nothing in this article should be used as a reason to delay seeking medical advice.
• No product or service claims. References to homeopathic medicines, preparations, potencies, companies, organisations, practitioners or countries are for historical and educational illustration only. They are not endorsements or recommendations, and this article is not an advertisement for any product or service.
• Remedies named in the text. Remedies named in tables and examples, including polychrests, trios, miasms and the case-taking teaching example, are described as they appear in the traditional homeopathic literature, for educational purposes only. They are not recommendations for treating any person or condition, and no remedy should be used for a serious or persistent condition without professional assessment.
• Research. Descriptions of studies summarise published findings and their reported limitations. They do not constitute a claim that homeopathy, or any homeopathic product, is effective for any specific condition.
• Regulatory and GMP information. Summaries of laws, regulations, pharmacopoeias and Good Manufacturing Practice requirements are simplified, may be incomplete, and may change. Requirements vary between countries. Manufacturers, practitioners and others should consult the current official texts and the competent authorities, and obtain professional regulatory or legal advice where needed.
• International readers. This article is published for readers worldwide. Laws on medicines, health practitioners and advertising differ between countries, and the regulatory sections describe the United Kingdom in most detail. Nothing in this article is intended as an advertisement or as a health claim in any jurisdiction, and readers should follow the laws and professional guidance that apply where they live.
• Accuracy. Information is believed to be accurate at the date of publication, but no warranty, express or implied, is given as to its completeness, accuracy or currency.
• Limitation of liability. To the fullest extent permitted by law, the author accepts no liability for any loss, injury or damage arising from the use of, or reliance on, the information in this article.
• Views. Opinions and interpretations expressed are those of the author.

© 2026 Maq Masi. All rights reserved. This article may be quoted briefly with attribution; it may not be reproduced in full without the author’s permission.

Appendices

Timeline of key dates

Year	Event
1755	Hahnemann born in Meissen, Saxony
1790	Hahnemann’s cinchona experiment
1796	Hahnemann’s essay on a new principle; conventional start of homeopathy
1810	First edition of the Organon
1825	Hans Burch Gram introduces homeopathy to the United States
1827	Frederic Quin introduces homeopathy to Britain
1828	The Chronic Diseases and the theory of miasms
1843	Death of Hahnemann in Paris
1844	American Institute of Homeopathy and British Homoeopathic Society founded
1846	Bönninghausen’s Therapeutic Pocket Book
1849	London Homoeopathic Hospital founded
1867	Mahendralal Sircar publicly declares his support for homeopathy in India
1870	First British Homoeopathic Pharmacopoeia
1897	Kent’s Repertory published
1898	E. B. Nash’s Leaders in Homoeopathic Therapeutics
1900	Kent’s Lectures on Homoeopathic Philosophy
1908	J. H. Allen’s The Chronic Miasms
1921	Sixth edition of the Organon published posthumously
1930s	Edward Bach develops his 38 flower remedies
1936	Hans-Heinrich Reckeweg founds Heel
1938	The HPUS recognised as an official compendium under US federal law
1980	Homeopathy recognised as a medical specialty in Brazil
2006	UK Homeopathic National Rules Scheme introduced; homeopathy included in Brazil’s public health system
2009	Swiss voters approve complementary medicine in a national vote
2017	Physician-delivered homeopathy covered by Swiss basic health insurance
2020	India’s National Commission for Homoeopathy Act passed
2022	Revised EU GMP Annex 1 on sterile manufacture published
2025	Homeopathic products authorised on a UK-wide basis under the Windsor Framework

Glossary

Term	Meaning
Aggravation	A temporary worsening of symptoms after a remedy, traditionally interpreted as a sign of action; significant or prolonged worsening is medically assessed
Aphorism	A numbered paragraph of the Organon
Avogadro limit	The dilution, around 12C, beyond which on average no molecule of the original substance is expected to remain
Constitutional remedy	A remedy chosen on the person’s overall temperament and tendencies
Dynamisation	Hahnemann’s term for potentisation, which he believed develops the latent medicinal power of a substance
GMP	Good Manufacturing Practice: the quality system for making medicines
HR / NR	UK registration (Simplified scheme) and authorisation (National Rules) numbers
Isopathy	Use of a preparation of the substance thought to cause the illness
Materia medica	A reference describing the symptoms attributed to each remedy
Miasm	Hahnemann’s concept of an underlying chronic disease tendency (psora, sycosis, syphilis, and later additions)
Modality	A circumstance that makes a symptom better or worse
Mother tincture (Ø)	The initial extract from which dilutions are made; may contain active substances
Nosode	A preparation made from disease material or microorganisms; not a vaccine
Polychrest	A remedy with a very wide range of action and frequent use
Potency	The number of dilution-and-succussion steps a preparation has undergone
Potentisation	Repeated dilution with succussion or trituration
Proving	Systematic administration of a substance to healthy volunteers to record the symptoms it produces
Repertorisation	Comparing remedies by translating a patient’s symptoms into repertory rubrics
Repertory	An index of symptoms listing associated remedies
Rubric	A single symptom heading in a repertory, with its list of remedies
Sarcode	A preparation made from healthy tissue or physiological substances
Simillimum	The single remedy that most closely matches the patient’s symptoms
Succussion	Vigorous shaking with impact at each dilution step
Trio	A group of three remedies sharing a prominent feature, studied together for comparison
Trituration	Grinding an insoluble substance with lactose
Vital force	Hahnemann’s concept of the dynamic life principle, disturbed in illness

References and further reading

The following sources support the factual statements in this article. Readers should consult the current versions, as regulations and positions change.

Primary historical works

• Hahnemann S. Organon of Medicine, 6th edition (1842, published 1921).
• Hahnemann S. The Chronic Diseases (1828).
• Kent JT. Lectures on Homoeopathic Philosophy (1900); Repertory of the Homoeopathic Materia Medica (1897).
• Boericke W. Pocket Manual of Homoeopathic Materia Medica (1901 and later editions).
• Bach E. The Twelve Healers and Other Remedies (1936 edition).

Evidence reviews and official positions

• Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homoeopathy. BMJ 1991; 302: 316–323.
• Linde K, et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. The Lancet 1997; 350: 834–843.
• Jacobs J, et al. Homeopathy for childhood diarrhea: combined results and metaanalysis from three randomized, controlled clinical trials. Pediatric Infectious Disease Journal 2003; 22(3): 229–234.
• Shang A, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. The Lancet 2005; 366: 726–732.
• Spence DS, Thompson EA, Barron SJ. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. Journal of Alternative and Complementary Medicine 2005; 11(5): 793–798.
• Witt CM, et al. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health 2005; 5: 115.
• Lüdtke R, Rutten ALB. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. Journal of Clinical Epidemiology 2008; 61(12): 1197–1204.
• House of Commons Science and Technology Committee. Evidence Check 2: Homeopathy (2010).
• Hahn RG. Homeopathy: meta-analyses of pooled clinical data. Forschende Komplementärmedizin 2013; 20(5): 376–381.
• Mathie RT, et al. Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Systematic Reviews 2014; 3: 142.
• National Health and Medical Research Council. NHMRC Information Paper: Evidence on the effectiveness of homeopathy for treating health conditions (2015).
• European Academies’ Science Advisory Council. Homeopathic products and practices (2017).
• NHS England. Items which should not be routinely prescribed in primary care (2017).
• Chikramane PS, et al. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 2010; 99(4): 231–242.

Regulation, advertising and registers (UK)

• MHRA. Register a homeopathic medicine or remedy.
• MHRA. Labelling requirements for homeopathic products.
• MHRA. The manufacture and control of dosage forms for homeopathics.
• MHRA. Blue Guide, Appendix 2: advertising of homeopathic products.
• ASA / CAP. Health: Homeopathy (advice online).
• ASA. Advertising standards for homeopathy (2016).
• Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Articles 13–16, homeopathic medicinal products).
• US Food and Drug Administration. Homeopathic Drug Products: Guidance for FDA Staff and Industry (2022).
• US Federal Trade Commission. Enforcement Policy Statement on Marketing Claims for OTC Homeopathic Drugs (2016).
• Health Canada. Natural and Non-prescription Health Products: homeopathic medicines.

Manufacturing standards

• European Commission. EudraLex Volume 4, EU GMP Guidelines, Annex 1: Manufacture of Sterile Medicinal Products (2022).
• ISO 14644-1:2015. Cleanrooms and associated controlled environments — Classification of air cleanliness by particle concentration.
• European Pharmacopoeia, general chapter 5.1.4 (microbiological quality of non-sterile preparations) and homeopathic monographs.
• German Homoeopathic Pharmacopoeia (HAB); Homoeopathic Pharmacopoeia of the United States (HPUS); Homoeopathic Pharmacopoeia of India.

Global use and recognition

• World Health Organization. WHO global report on traditional and complementary medicine 2019.
• Ministry of Ayush, Government of India: registered homoeopathy practitioners and facilities (2025).
• Swissinfo. Coverage of complementary medicine under Swiss basic health insurance.
• Ministério da Saúde, Brasil. Política Nacional de Práticas Integrativas e Complementares no SUS (2006).
• HPUS. The legal status of the HPUS as an official compendium (2022).
• Connecticut General Assembly, Office of Legislative Research. Homeopathic physician licensure (2010).